Open AccessFavipiravir: a promising investigational agent in preventing infection and progression of COVID-19
Author(s) -
Sidharth Mehta,
Himanshi Tanwar,
Pooja Ran
Publication year - 2022
Publication title -
clinical research communications
Language(s) - English
Resource type - Journals
ISSN - 2815-7176
DOI - 10.53388/crc20220005
Subject(s) - favipiravir , covid-19 , investigational drugs , medicine , virology , rescue therapy , intensive care medicine , clinical trial , infectious disease (medical specialty) , outbreak , disease